Annual SGA
$114.33 M
-$74.03 M-39.30%
December 31, 2024
Summary
- As of March 12, 2025, AMLX annual SGA is $114.33 million, with the most recent change of -$74.03 million (-39.30%) on December 31, 2024.
- During the last 3 years, AMLX annual SGA has risen by +$75.40 million (+193.66%).
- AMLX annual SGA is now -39.30% below its all-time high of $188.36 million, reached on December 31, 2023.
Performance
AMLX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$17.10 M
-$731.00 K-4.10%
December 31, 2024
Summary
- As of March 12, 2025, AMLX quarterly SGA is $17.10 million, with the most recent change of -$731.00 thousand (-4.10%) on December 31, 2024.
- Over the past year, AMLX quarterly SGA has dropped by -$35.14 million (-67.27%).
- AMLX quarterly SGA is now -70.40% below its all-time high of $57.76 million, reached on March 31, 2024.
Performance
AMLX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.10 B
-$301.74 M-16.82%
December 31, 2024
Summary
- As of March 12, 2025, AMLX TTM SGA is -$2.10 billion, with the most recent change of -$301.74 million (-16.82%) on December 31, 2024.
- Over the past year, AMLX TTM SGA has dropped by -$2.28 billion (-1212.80%).
- AMLX TTM SGA is now -2986.29% below its all-time high of -$67.91 million.
Performance
AMLX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AMLX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.3% | -67.3% | -1212.8% |
| 3 y3 years | +193.7% | -64.9% | -1284.5% |
| 5 y5 years | +3610.8% | -64.9% | -1284.5% |
AMLX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.3% | +193.7% | -70.4% | +14.6% | -639.7% | at low |
| 5 y | 5-year | -39.3% | +3610.8% | -70.4% | +335.1% | -2986.3% | at low |
| alltime | all time | -39.3% | +3610.8% | -70.4% | +335.1% | -2986.3% | at low |
Amylyx Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $114.33 M(-39.3%) | $17.10 M(-4.1%) | $114.33 M(-23.5%) |
| Sep 2024 | - | $17.83 M(-17.6%) | $149.47 M(-17.1%) |
| Jun 2024 | - | $21.65 M(-62.5%) | $180.37 M(-10.8%) |
| Mar 2024 | - | $57.76 M(+10.6%) | $202.11 M(+7.3%) |
| Dec 2023 | $188.36 M(+48.2%) | $52.24 M(+7.2%) | $188.36 M(+6.4%) |
| Sep 2023 | - | $48.72 M(+12.3%) | $176.96 M(+11.9%) |
| Jun 2023 | - | $43.39 M(-1.4%) | $158.18 M(+9.3%) |
| Mar 2023 | - | $44.01 M(+7.7%) | $144.78 M(+13.9%) |
| Dec 2022 | $127.13 M | $40.84 M(+36.4%) | $127.13 M(+25.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $29.94 M(-0.2%) | $101.20 M(+24.0%) |
| Jun 2022 | - | $29.99 M(+13.8%) | $81.61 M(+37.7%) |
| Mar 2022 | - | $26.35 M(+76.6%) | $59.28 M(+52.3%) |
| Dec 2021 | $38.93 M(+158.5%) | $14.92 M(+44.2%) | $38.93 M(+39.3%) |
| Sep 2021 | - | $10.35 M(+35.2%) | $27.94 M(+58.8%) |
| Jun 2021 | - | $7.66 M(+27.5%) | $17.59 M(+77.1%) |
| Mar 2021 | - | $6.00 M(+52.8%) | $9.93 M(+152.8%) |
| Dec 2020 | $15.06 M(+388.8%) | $3.93 M | $3.93 M |
| Dec 2019 | $3.08 M | - | - |
FAQ
- What is Amylyx Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual SGA year-on-year change?
- What is Amylyx Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly SGA year-on-year change?
- What is Amylyx Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals TTM SGA year-on-year change?
What is Amylyx Pharmaceuticals annual SGA?
The current annual SGA of AMLX is $114.33 M
What is the all time high annual SGA for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual SGA is $188.36 M
What is Amylyx Pharmaceuticals annual SGA year-on-year change?
Over the past year, AMLX annual SGA has changed by -$74.03 M (-39.30%)
What is Amylyx Pharmaceuticals quarterly SGA?
The current quarterly SGA of AMLX is $17.10 M
What is the all time high quarterly SGA for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly SGA is $57.76 M
What is Amylyx Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, AMLX quarterly SGA has changed by -$35.14 M (-67.27%)
What is Amylyx Pharmaceuticals TTM SGA?
The current TTM SGA of AMLX is -$2.10 B
What is the all time high TTM SGA for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high TTM SGA is -$67.91 M
What is Amylyx Pharmaceuticals TTM SGA year-on-year change?
Over the past year, AMLX TTM SGA has changed by -$2.28 B (-1212.80%)